SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-056196
Filing Date
2023-07-11
Accepted
2023-07-11 16:05:08
Documents
14
Period of Report
2023-07-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea181570-8k_allarity.htm   iXBRL 8-K 43263
2 THIRD CERTIFICATE OF AMENDMENT (SERIES A PREFERRED STOCK) ea181570ex3-1_allarity.htm EX-3.1 9171
3 FORM OF AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT ea181570ex4-1_allarity.htm EX-4.1 113557
  Complete submission text file 0001213900-23-056196.txt   378864

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE allr-20230705.xsd EX-101.SCH 3004
5 XBRL LABEL FILE allr-20230705_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE allr-20230705_pre.xml EX-101.PRE 22819
8 EXTRACTED XBRL INSTANCE DOCUMENT ea181570-8k_allarity_htm.xml XML 3989
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 231082208
SIC: 2834 Pharmaceutical Preparations